Wu Y, Hu L, Xie X, Li W, et al. Different Dose Aspirin Plus Immunoglobulin (DAPI) for Prevention of Coronary Artery Abnormalities in Kawasaki Disease: Study Protocol for a Multi-centre, Prospective, Randomized, Open-label, Blinded End-point, Non-inferiority Trial. Am Heart J 2024 Mar 18:S0002-8703(24)00071-1. doi: 10.1016/j.ahj.2024.
PMID: 38508571